{"product_id":"mer-primary-care-conferences-internal-medicine-for-primary-care-cardio-endo-id-rheum-mar-30-apr-02-2026","title":"MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo ID Rheum Mar 30 – Apr 02, 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  file sub vtt, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physicians, cardiologists, endocrinologists, rheumatologists, infectious disease physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe “Internal Medicine for Primary Care: Cardiology\/Endocrinology\/Infectious Diseases\/Rheumatology” is a conference organized by Medical Education Resources (MER), a non-profit organization.\u003c\/p\u003e\n\u003cp\u003eThe event is scheduled to take place from March 30 to April 2, 2026, at the Hilton Lake Como in Lake Como, Italy.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eDevelop patient-specific treatment plans for the management of type 2 diabetes.\u003c\/p\u003e\n\u003cp\u003eInterpret the diagnostic criteria for dyslipidemia and design individualized treatment.\u003c\/p\u003e\n\u003cp\u003eIdentify the risks and benefits of utilizing bisphosphonates in the treatment of osteoporosis.\u003c\/p\u003e\n\u003cp\u003eIdentify the risks of abnormal thyroid function.\u003c\/p\u003e\n\u003cp\u003eDescribe the differential diagnoses of inflammatory arthritis based on clinical presentation and laboratory workup.\u003c\/p\u003e\n\u003cp\u003eUtilize current evidence to design treatment strategies for osteoarthritis.\u003c\/p\u003e\n\u003cp\u003eDiagnose and treat gout and pseudogout.\u003c\/p\u003e\n\u003cp\u003eCompare the benefits and side effect profiles of pharmacologic treatment options for fibromyalgia.\u003c\/p\u003e\n\u003cp\u003eList common causative pathogens for various respiratory tract infections.\u003c\/p\u003e\n\u003cp\u003eEvaluate the severity of diarrhea and evaluate the need for treatment.\u003c\/p\u003e\n\u003cp\u003eDiscuss emerging infectious diseases including resurgence of vaccine-preventable diseases, zoonoses, and diseases related to animal exposures.\u003c\/p\u003e\n\u003cp\u003eDescribe the work-up, risk assessment and test selection of patients with suspected CAD.\u003c\/p\u003e\n\u003cp\u003eExplain current concepts in the diagnosis and treatment of hypertension.\u003c\/p\u003e\n\u003cp\u003eImplement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure.\u003c\/p\u003e\n\u003cp\u003eDescribe current diagnostic and treatment approaches to arrhythmias and atrial fibrilation.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eEndocrinology\u003c\/p\u003e\n\u003cp\u003eType 2 Diabetes Mellitus: Diagnosis and treatment; lessons from the DCCT; managing diabetic emergencies; screening; pre-diabetes.\u003c\/p\u003e\n\u003cp\u003eDisorders of Thyroid Function: Prevalence, diagnosis and treatment options of hypothyroidism and hyperthyroidism.\u003c\/p\u003e\n\u003cp\u003eRheumatology\u003c\/p\u003e\n\u003cp\u003eDifferential Diagnosis of Inflammatory Arthritis: Clinical presentation and laboratory work-up and treatment for rheumatoid arthritis, systemic lupus erythematosus, spondyloarthropathies (SPA), infectious arthritis and systemic sclerosis; Treatment of RA with DMARDs; Treatment principles of SLE, Sjogren’s, SPA and PMR.\u003c\/p\u003e\n\u003cp\u003eOsteoarthritis: Pathogenesis, diagnosis and treatment.\u003c\/p\u003e\n\u003cp\u003eCrystal Disease: Gout \u0026amp; Pseudogout: Properly diagnosing and treating crystal diseases such as gout and pseudogout.\u003c\/p\u003e\n\u003cp\u003eFibromyalgia: Differential diagnosis and treatment of this difficult-to-manage pain syndrome; Treatment options of anti-epileptics and SNRI’s.\u003c\/p\u003e\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\u003cp\u003eSkin \u0026amp; Soft Tissue Infections: Presentation on important skin and soft-tissue infections and their prompt recognition, emphasizing evaluation and management strategies.\u003c\/p\u003e\n\u003cp\u003eRespiratory Tract Infections: Discussion highlighting critical points regarding the diagnosis and management of pneumonia and bronchitis – with a focus on the impact of multidrug resistant pathogens.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Infections \u0026amp; Clostridiodes Difficile: Presentation on important enteric pathogens and their recognition, diagnosis and management; special emphasis on clostridiodes difficile colitis and related updates from the ID and infection control literature.\u003c\/p\u003e\n\u003cp\u003eEmerging Infectious Diseases: Novel influenza viruses, resurgence of vaccine-preventable diseases, zoonoses and disease related to animal exposures (including vectors such as mosquitoes that bear west Nile virus and dengue), bioterrorism and food\/waterborne illness.\u003c\/p\u003e\n\u003cp\u003eCardiology\u003c\/p\u003e\n\u003cp\u003eWork-up of Patients with Suspected CAD: Risk factor evaluation and risk assessment models; Test selection including ECG, echo, nuclear and newer imaging modalities (including discussion of appropriate use criteria–AUC); The usefulness of CT scanning; The role of bio markers and EBCT; Suspected CAD in special populations (women, diabetics, the elderly).\u003c\/p\u003e\n\u003cp\u003eHypertension: The 2017 AHA\/ACC Hypertension Guidelines; The 2024 ESC Guidelines for hypertension; Approaches to treatment thresholds and goals; Choices for initial and combination therapy; Resistant hypertension; Treating special populations: diabetics, the elderly, patients with renal failure.\u003c\/p\u003e\n\u003cp\u003eHeart Failure: Etiologies and stages of heart failure; ACC\/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices in treatment and antiplatelet drugs; Issues related to the hospitalized patient with acute decompensated heart failure and readmissions.\u003c\/p\u003e\n\u003cp\u003eArrhythmias: Types and symptoms of arrhythmias; Approach to the patient: when to treat, when to refer, when to admit; Evaluation of the patient with palpitations; Atrial fibrilation: the use of anticoagulants indications, CVA risk scores, warfarin vs newer oral anticoagulants, controlling heart rate vs rhythm; Ventricular and other arrhythmias: when are they serious.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405756911812,"sku":null,"price":195.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/MER-Primary-Care-Conferences-Internal-Medicine-for-Primary-Care-Cardio-Endo-ID-Rheum-Mar-30-Apr-02-2026.jpg?v=1784215775","url":"https:\/\/medicalcoursespro.com\/products\/mer-primary-care-conferences-internal-medicine-for-primary-care-cardio-endo-id-rheum-mar-30-apr-02-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}